Psychostimulant drug abuse, dependence and withdrawal are associated with cognitive dysfunction and impact stress-sensitive systems. The corticotropin-releasing factor (CRF) system orchestrates stress responses via CRF 1 and CRF 2 receptors and is implicated in substance use disorders. However, CRF 2 role in psychostimulant drug-induced cognitive dysfunction remains to be elucidated. In the present study, wild-type and CRF 2 −/− mice are injected with cocaine and memory assessed by the novel object recognition (NOR) task throughout relatively long periods of drug withdrawal. Following recovery from the drug-induced memory deficits, the mice are stressed prior to the NOR task and brain gene expression evaluated by in situ hybridization. Cocaine impairs NOR memory in wild-type and CRF 2 −/− mice. However, following cocaine withdrawal NOR memory deficits last less time in CRF 2 −/− than in wild-type mice. Furthermore, a relatively mild stressor induces the reemergence of NOR deficits in long-term cocaine-withdrawn wild-type but not CRF 2 −/− mice. Cocainewithdrawn mice show a genotype-independent higher c-fos expression in the NOR memory-relevant perirhinal cortex than drug-naïve mice. However neither genotype nor drug withdrawal affect the expression of tyrosine hydroxylase in the ventral tegmental area or the locus coeruleus and CRF in the central nucleus of the amygdala or the paraventricular nucleus of the hypothalamus, brain regions implicated in stress and drug responses. These data indicate a new role for the CRF 2 receptor in cognitive deficits induced by cocaine withdrawal, both as regards to their duration and their re-induction by stress. Interestingly, prototypical brain stress systems other than CRF do not appear to be involved.
Introduction
By analogy to many psychiatric disorders, psychostimulant drug use often induces cognitive dysfunction (Millan et al., 2012; APA, 2013) . For instance, cocaine and methamphetamine users display high impulsivity, bad decision-making and memory impairment (Bolla et al., 2000; Kirby and Petry, 2004; Fox et al., 2009) . Notably, upon cessation of psychostimulant drug intake cognitive dysfunction may last for relatively long time periods (Moon et al., 2007) . Mirroring these observations, psychostimulant drug administration and withdrawal disrupt cognitive performance of rodents tested in the five-choice serial reaction time, the Morris water maze and the novel object recognition (NOR) tests (Bisagno et al., 2002; Briand et al., 2008; Mendez et al., 2008) . Thus, animal models may be used for understanding the brain mechanisms underlying psychostimulant drug-induced cognitive deficits and the discovery of therapeutic strategies for their alleviation.
The corticotropin-releasing factor (CRF) system, a major coordinator of neuroendocrine and behavioural responses to stressors (Koob, 1999) , appears to be involved in the effects of psychostimulant drug administration and withdrawal. For instance, in rats, cocaine administration and withdrawal increase the extracellular levels of CRF in the central nucleus of the amygdala (CeA), a brain region implicated in the aversive effects of drugs of abuse (Richter et al., 1995; Richter and Weiss, 1999; Phelps and LeDoux, 2005) . Moreover, CRF antagonists attenuate the negative affective-like states and the stress-induced reinstatement of cocaine-seeking behaviour in cocaine-withdrawn rats (Erb et al., 1998; Basso et al., 1999) . CRF signalling is mediated by two receptor types, CRF 1 and CRF 2 (Hauger et al., 2003) , which may differentially contribute to the effects of substance administration and withdrawal. In particular, CRF 1 or CRF 2 receptor activity may increase or decrease, respectively, ethanol self-administration in rats . Moreover, CRF 1 or CRF 2 receptordeficiency exacerbates or abolishes, respectively, the somatic signs of spontaneous opiate withdrawal in mice (Papaleo et al., 2007 (Papaleo et al., , 2008 . Furthermore, the CRF system appears to differentially influence cognitive function under basal or stressful conditions. For instance, CRF-like peptides and CRF-binding protein inhibitors enhance learning and memory in unstressed rats, whereas CRF exerts a deleterious effect during stressful situations (Behan et al., 1995; Heinrichs et al., 1997; Zorrilla et al., 2002) . Although the latter evidence suggests the implication of the CRF system in learning and memory processes, an important issue concerns the respective roles for the CRF 1 vs. the CRF 2 receptor, which remain poorly defined. For instance, genetic disruption of the CRF 1 receptor in the forebrain attenuates chronic social defeat stress-induced NOR deficits (Wang et al., 2011) . Moreover, elevated CRF 2 receptor activity in mice overexpressing urocortin-3 impairs spatial memory in the aversive Barnes maze (Neufeld-Cohen et al., 2012) , suggesting similar roles for the CRF 1 and the CRF 2 receptors in stress-related cognitive processes. However, the role for the CRF 2 receptor in cognitive deficits induced by cocaine administration and withdrawal awaits elucidation. CRF 2 receptors are expressed in mouse brain regions implicated in the stress response, cognitive processes and the effects of drugs of abuse, such as the cortex, the ventral hippocampus, the lateral septum, the basolateral nucleus of the amygdala and the hypothalamus (Van Pett et al., 2000) . Expression of the CRF 2 receptor is also sensitive to substance withdrawal. For instance, decreased CRF 2 mRNA levels in the basolateral nucleus of the amygdala are found following naltrexone-precipitated opiate withdrawal or ethanol withdrawal in rats (Iredale et al., 2000; Sommer et al., 2008) .
Thus, in the present study CRF 2 receptor-deficient mice are used to assess the role for the CRF 2 receptor in cocaine-induced cognitive deficits. For this purpose, the NOR task, a paradigm commonly employed to assess recognition memory in rodents, is used (Bevins and Besheer, 2006) . The NOR task is based on the innate tendency of rodents to explore a novel object more than a familiar object, which per se are devoid of reinforcing properties. Thus, it may be suitable to specifically monitor cognitive function in drug-treated and -withdrawn animals, independently of possible drug-induced changes in motivation (Barr and Phillips, 1999; Rouibi and Contarino, 2012) . Herein, the effect of CRF 2 receptor-deficiency upon NOR memory is first examined in drug-naive mice. Then, studies investigate the role for the CRF 2 receptor in NOR memory deficits induced by administration of and withdrawal from escalating doses of cocaine. Moreover, following recovery from the drug-induced NOR memory deficits, the role for the CRF 2 receptor in the stress-induced re-emergence of memory deficits is assessed in long-term cocainewithdrawn mice. Finally, in situ hybridization experiments are conducted to search for other neuronal substrates underlying cognitive and stress vulnerability associated with long-term cocaine withdrawal. For this purpose, the expression of the immediate early gene c-fos, which is classically used as a marker of neuronal activity, is assessed in cognitive-relevant brain regions, such as the perirhinal cortex (PRh) and the prefrontal cortex (PFC) (Morgan et al., 1987; Barbosa et al., 2013) . Moreover, expression of CRF and the enzyme tyrosine hydroxylase (TH), which catalyses the rate-limiting step of dopamine and norepinephrine synthesis, is assessed in brain regions thought to be involved in the stress response and the aversive consequences of drug withdrawal, such as the ventral tegmental area (VTA), the locus coeruleus (LC), the paraventricular nucleus of the hypothalamus (PVN) and the CeA (Vrana et al., 1993; Koob, 1999 Koob, , 2008 Ingallinesi et al., 2012) .
Method

Subjects
Group-housed littermate wild-type (CRF 2 +/+, n = 19) or constitutive CRF 2 receptor null mutant (CRF 2 −/−; n = 23) male mice with a mixed C57BL/6J × 129 background are used throughout (Bale et al., 2000) . The mice derive from mating CRF 2 +/− mice, their genotype is determined by PCR analysis of tail DNA, and are three to six months old at the beginning of the experiment. Such a relatively large age range does not influence NOR performance in dug-naïve or -treated mice (Morisot and Contarino, unpublished observations). The mice are housed in a colony room (22 ± 2°C, relative humidity: 50-60%) on a 12-h light/dark cycle (lights on at 08:00) with standard laboratory food (3.3 kcal/g; SAFE, France) and water available ad libitum. All studies are conducted in accordance with the European Communities Council Directive of 24 November 1986 (86/609/EEC) and are approved by the local Animal Care and Use Committee. All efforts are made to minimize animal suffering and to reduce the number of animals used.
NOR and elevated platform apparatuses
The NOR apparatus is a dark grey polypropylene box (40 × 30 × 23 cm; length, width, height) divided in 12 squares (10 × 10 cm each) by lines drawn on the floor. A glass-made rectangle and a ceramic bowl are used for object recognition; they are about 5 cm high, too heavy to be displaced by the mouse and located 5 cm away from a corner of the apparatus. The mice do not show any preference for one or the other of the two objects (Morisot and Contarino, unpublished observations). The elevated platform is a square (10 × 10 cm) made of dark grey polypropylene and elevated about 40 cm above the floor.
Experimental procedure
Prior to the beginning of the experiments, over three consecutive days each animal is handled for 1 min per day. Experiments are conducted in the same cohort of animals that is repeatedly tested in the NOR test (Fig. 1) . All testing is conducted during the light phase of the 12 h light/ dark cycle in a quiet room dimly illuminated (30 lux). During the two days preceding the first NOR test and on the day preceding the subsequent NOR tests, the animal is allowed to freely explore the empty (without objects) apparatus for 10 min (habituation trial). The NOR test consists of two trials (T1 and T2) separated by an inter-trial time interval (ITI). On T1 (acquisition trial), the mice are placed in the apparatus containing two identical objects (F1 and F2) for 10 min. The mice are then returned to their home cage and, following a variable ITI (15 min -2 h), they are placed back into the NOR apparatus containing a familiar (F) and a novel (N) object for 5 min (T2, restitution trial). The role (familiar or novel) and the position (left or right) of the two objects is counterbalanced and randomized within each experimental group. Between each trial, the NOR apparatus is cleaned with water and the objects with 50% ethanol. Exploration is defined as the animal directing the nose within 0.5 cm of the object while looking at, sniffing or touching it, excluding accidental contacts with it (backing into, standing on the object, etc.). The experiments are recorded on a video system and time spent exploring the objects scored by a trained observer. To assess the duration of NOR memory, the drug-naïve mice are tested in the NOR task once a week using gradually increasing ITI (15 min, 1 and 2 h). Then, within genotype, the mice are assigned to receive physiological saline (10 ml/kg, i.p.) or cocaine hydrochloride (Coopération Pharmaceutique Française, France) every 12 h (08:00-20:00), and over eleven consecutive days, as follows: day 1: 5 mg/kg; days 2 and 3: 10 mg/kg; days 4, 5 and 6: 15 mg/kg; days 7, 8, 9 and 10: 20 mg/kg; day 11, 20 mg/kg only one injection in the morning. The mice are weighed immediately before each injection and body weight changes calculated as percentage of the body weight recorded just prior to the first injection. Then, NOR memory is assessed using a 1 h ITI immediately (day 11 of treatment) and once a week after the last injection up to 35 days of cocaine withdrawal. To assess ambulation, total line crossing during the NOR test is also measured. Then, to examine stress vulnerability during long-term cocaine withdrawal (42 days after the last injection), the mice are exposed to the elevated platform stressor for 10 min and tested in the NOR task 1 h later, since this time interval does not affect the performance of drug-naive mice (Morisot and Contarino, unpublished observations). Then, to explore the neuronal substrates underlying stress vulnerability, brains are rapidly removed 45 min after the NOR test, frozen in isopentane (−40°C) and stored at −80°C for later in situ hybridization experiments.
In situ hybridization
Brains are cut in coronal sections (12 μm) using a cryostat and thaw mounted onto gelatin-coated slides, as previously described (Frenois et al., 2005) . The Paxinos and Franklin mouse brain atlas is used to identify the different brain regions examined (Paxinos and Franklin, 2001) . In situ hybridization is performed with antisense 35 S-labeled complementary RNA probes designed to recognize c-fos, TH (Frenois et al., 2005) and CRF (Juaneda et al., 2001) mRNAs. All probes are prepared by in vitro transcription from 100 ng of linearized plasmid using [ 35 S]UTP (>1000 Ci/mmol; Perkin-Elmer Life Sciences, France) and appropriate RNA polymerases. After alkaline hydrolysis to obtain 0.25 kb complementary RNA fragments, the 35 S-labeled probes are purified on G50-Sephadex and precipitated in sodium acetate 3M, pH 5.0 (0.1 volume), absolute ethanol (2.5 volumes). Sections are post-fixed in 4% paraformaldehyde for 5 min at room temperature, rinsed twice in 4 × sodium chloride-sodium citrate buffer (SSC) and placed into 0.1M triethanolamine/4 × SSC, pH 8.0, for 10 min at room temperature; 0.25% acetic anhydride is added for the last 5 min. After dehydration in graded alcohols, sections are hybridized overnight at 55°C with 10 6 c.p.m. of antisense 35 S-labeled probes in 50 μl of hybridization buffer (20 mM Tris-HCl, 1 mM EDTA, 300 mM NaCl, 50% formamide, 10% dextran sulphate and 1% Denhardt). The slides are rinsed in 4 × SSC twice, treated with RNAse A for 15 min at 37°C, washed in decreasing SSC concentrations at room temperature and then at 65°C with 0.1 × SSC for 30 min twice. Slides are dehydrated and then exposed at room temperature to Biomax-MR X-ray film (Kodak, Eastman Kodak, USA) for two to ten weeks. Quantification of mRNA expression is performed Wild-type and CRF 2 −/− mice are tested (ticks) once a week in the novel object recognition (NOR) task using a 15 min, a 1 h and a 2 h inter-trial interval (ITI). Cocaine is injected i.p. twice a day (08:00-20:00) at the dose indicated, except for the last day when only one injection is given in the morning immediately before the NOR test. On cocaine withdrawal day 42, the mice are exposed to an elevated platform stressor 1 h prior to the acquisition trial (T1) of the NOR test, and brains collected 45 min after the end of the restitution trial (T2).
by densitometric analysis on X-ray film and data are expressed as mean of optical density±S.E.M.
Statistical analysis
Only animals exploring the objects for at least 10 or 5 s during T1 or T2, respectively, or one of the 2 objects for no more than 70% of the total object exploration time during T1, are included in the study. Thus, repeated measure analyses are not used because of missing values during one or more NOR tests. A two-way analysis of variance (ANOVA) is used to examine the time spent exploring objects on T1 and T2 in drug-naïve mice, with genotype (wild-type vs. CRF 2 −/−) as a between subject factor and objects (F1 vs. F2; F vs. N) as a within-subject factor. A two-way ANOVA is used to examine the effect of re-testing upon total exploration time on T1 with genotype and tests (15 min, 1 or 2 h ITI) as between subject factors. A three-way ANOVA is used to examine body weight loss, with genotype and treatment (saline vs. cocaine) as between subject factors and treatment days as a within-subject factor. A three-way ANOVA is used to examine the effect of chronic cocaine administration, cocaine withdrawal and stress upon the time spent exploring objects on T1 or T2, with genotype and treatment as between subject factors and objects as a within-subject factor. A two-way ANOVA is used to examine total line crossing and optical density (mRNA expression) with genotype and treatment as between subject factors. The Newman-Keuls test is used for individual group comparisons. The accepted value for significance is p < 0.05.
Results
Unaltered NOR memory in drug-naïve CRF 2 receptor-deficient mice During T1, mice similarly explore F1 and F2 in a genotype-independent manner (object effect, 15 min ITI: F 1,38 = 1.39, p = 0.25; 1 h ITI: F 1,37 = 0.29, p = 0.59; 2 h ITI: F 1,39 = 0.63, p = 0.43; Fig. S1a , S1c, S1e). However, the repeated exposure to the NOR test leads to a progressive genotype-independent decrease in the total time spent exploring objects during T1 (F 2,114 = 39.53, p < 0.0001). Indeed, during the second and the third T1 tests mice spend less time exploring objects than during the first T1 test (p < 0.0001; insert Fig. S1 ). During T2, mice spend more time exploring the novel than the familiar object when a 15 min (object effect: F 1,38 = 73.93, p < 0.0001; Fig. S1b ), a 1 h (object effect: F 1,37 = 56.81, p < 0.0001; Fig. S1d ) and a 2 h (object effect: F 1,39 = 9.54, p < 0.005; Fig. S1f ) ITI is applied, independently of genotype. Overall, these results indicate that CRF 2 receptordeficiency does not affect recognition memory under drug-naïve conditions. However, during the 2 h ITI NOR test memory performance is quite low. Thus, the 1 h ITI is used to further explore the role for the CRF 2 receptor in cocaine administration and withdrawal effects.
CRF 2 receptor-deficiency does not affect NOR memory deficits induced by cocaine administration
Intermittent injections of escalating doses of cocaine induce a body weight loss that is evident starting 12 h after the tenth drug injection (treatment × day effect: F 9,342 = 3.43, p < 0.0005; Fig. S2 ). During the T1 carried out immediately after the last injection, cocaine decreases the time spent exploring the familiar objects (treatment effect: F 1,35 = 20.76, p < 0.0005; Fig. 2a) . Moreover, cocaine increases ambulation, as assessed by line crossing (treatment effect: F 1,35 = 162.70, p < 0.0001; Fig. S3 ). During T2, a treatment X object interaction effect (F 1,35 = 45.43, p < 0.0001) reveals that saline-, but not cocaine-treated, mice spend more time exploring the novel than the familiar object, independently of genotype (Fig. 2b) . Thus, CRF 2 receptor-deficiency does not affect NOR memory deficits induced by the administration of escalating cocaine doses. CRF 2 receptor-deficiency shortens the NOR memory deficits induced by cocaine withdrawal
During the T1 carried out fourteen days after the last injection, saline-and cocaine-withdrawn mice similarly explore F1 and F2 (object effect: F 1,37 = 0.07, p = 0.79), in a genotype-independent manner (Fig. 3a) . During T2, a treatment × object interaction effect (F 1,37 = 25.99, p < 0.0001) reveals that saline-, but not cocaine-withdrawn, mice spend more time exploring the novel than the familiar object (Fig. 3b) . During the T1 carried out 28 days after the last injection, saline-and cocainewithdrawn mice similarly explore F1 and F2 (object effect: F 1,37 = 0.16, p = 0.69), in a genotype-independent manner (Fig. 3c) . However, during T2 a genotype × treatment × object interaction effect (F 1,37 = 6.50, p < 0.05) reveals that cocaine-withdrawn wild-type mice similarly explore the novel and the familiar object (p = 0.13), indicating impaired NOR memory (Fig. 3d) . In contrast, cocainewithdrawn CRF 2 −/− mice, saline-withdrawn wild-type and CRF 2 −/− mice spend more time exploring the novel than the familiar object (p < 0.005), revealing NOR memory (Fig. 3d) . These results indicate that cocaine withdrawal-induced recognition memory deficits last less in CRF 2 −/− than in wild-type mice.
CRF 2 receptor-deficiency abolishes the stress-induced re-emergence of NOR memory deficits following long-term cocaine withdrawal
During the T1 carried out 35 days after the last injection, saline-and cocaine-withdrawn mice similarly explore F1 and F2 (object effect: F 1,37 = 2.31, p = 0.14), in a genotypeindependent manner (Fig. 4a) . During T2, saline-and cocaine-withdrawn wild-type and CRF 2 −/− mice spend more time exploring the novel than the familiar object (object effect: F 1,37 = 91.17, p < 0.0001), indicating recovery from cocaine withdrawal-induced NOR memory deficits also in the wild-type mice (Fig. 4b) . During the T1 carried out after exposure to the elevated platform stressor on cocaine withdrawal day 42, saline-and cocaine-withdrawn mice similarly explore F1 and F2 (object effect: F 1,38 = 1.09, p = 0.30), independently of genotype (Fig. 4c) . However, during T2 a genotype × treatment × object interaction effect (F 1,38 = 8.02, p < 0.01) reveals that cocaine-withdrawn wild-type mice similarly explore the novel and the familiar object (p = 0.71), indicating a stress-induced re-emergence of NOR memory deficits (Fig. 4d) . In contrast, cocaine-withdrawn CRF 2 −/− mice, saline-withdrawn wild-type and CRF 2 −/− mice spend more time exploring the novel than the familiar object (p < 0.0005), indicating NOR memory (Fig. 4d) . These results show that CRF 2 receptor-deficiency eliminates the recognition memory deficits 'precipitated' by a relatively mild environmental stressor a long time after the last cocaine administration.
Long-term cocaine withdrawal is associated with increased perirhinal cortex activity
Following stress exposure, cocaine-withdrawn mice show a genotype-independent higher c-fos expression in the rostral PRh than saline-withdrawn mice (F 1,39 = 5.30, p < 0.05; Fig. 5a,b) . However, cocaine withdrawal does not affect c-fos expression in the caudal PRh ( Fig. S5c,d ). Thus, a long time after cocaine withdrawal the CRF 2 receptor-dependent stress-precipitated NOR memory deficit is not associated with alterations in other drug-and stress-related brain substrates.
Discussion
Summary of the results
To summarize core findings, the present study reveals a key role for the CRF 2 receptor in mediating cognitive dysfunction and stress vulnerability associated with psychostimulant drug withdrawal. Thus, after cessation of chronic cocaine administration NOR memory deficits last less in CRF 2 receptor-deficient than in wild-type mice. Furthermore, following recovery exposure to an environmental stressor 'precipitates' NOR memory deficits in long-term cocaine-withdrawn wild-type but not CRF 2 receptor-deficient mice. Finally, long-term cocaine withdrawal increases neuronal activity (c-fos expression) in the PRh, a brain structure underlying NOR memory, but does not affect CRF or TH expression in brain circuits relevant to stress-related effects of psychostimulant drugs.
The CRF 2 receptor mediates the duration of cocaine withdrawal-induced cognitive dysfunction
The current study shows that intermittent injections of escalating doses of cocaine induce recognition memory deficits in mice. Furthermore, following drug discontinuation cocaine-induced NOR memory deficits are observed for at least up to 28 days in wild-type mice. Prior studies report NOR memory deficits in rats four days, and one or two weeks after the cessation of ethanol, methamphetamine or cocaine administration, respectively (Belcher et al., 2005; Briand et al., 2008; Garcia-Moreno and Cimadevilla, 2012) . Thus, the present findings indicate that cognitive deficits induced by substances of abuse might be relatively long lasting following their discontinuation. Contrary to the drug-withdrawn wild-type mice, 28 days after the last drug injection cocainewithdrawn CRF 2 −/− mice show a full recovery from NOR memory deficits, as compared to control drugnaïve mice. Thus, CRF 2 receptor-deficiency effectively shortens the duration of cocaine-induced NOR memory deficits. Previous electrophysiology studies suggest the implication of the CRF system in cocaine-induced neuronal activity in brain regions mediating cognitive processes. Indeed, the local infusion of CRF into the PFC potentiates the cocaine-induced decrease in neuronal firing (Orozco-Cabal et al., 2008) . Moreover, a CRF 2 receptor-preferring antagonist attenuates the increased hippocampal long-term potentiation observed during a short-term (3 d) cocaine withdrawal (Guan et al., 2009 ). However, CRF role in neuronal electrophysiological changes following long-term cocaine withdrawal remains poorly understood.
The CRF 2 receptor mediates NOR memory vulnerability to stress following long-term cocaine withdrawal
Stress and negative affect might influence drug craving and promote drug-seeking and drug-taking behaviour in cocaine former users, even years after cessation of cocaine intake (Epstein et al., 2009; Sinha et al., 2011) . This makes it crucial to understand the neural mechanisms underlying the long-lasting vulnerability to stress following drug withdrawal. Thus, the present study also examines the effect of an environmental stressor upon the apparently recovered NOR memory following long-term drug withdrawal. Notably, stress effects are evaluated 42 days after cessation of cocaine administration, which is a relatively long period of drug withdrawal, as compared to prior rodent studies. Indeed, to reliably assess the role for the CRF 2 receptor in the stress-induced re-emergence of NOR deficits, mice are tested once a week up to NOR memory recovery in either the wild-type or the CRF 2 −/− cocaine-withdrawn mice. Thus, since either genotype show recovered NOR memory on drug withdrawal day 35, the effect of stress is evaluated on drug withdrawal day 42. It is well established that stress may influence cognitive function. For instance, CRFoverexpressing or CRF 1 receptor-deficient mice display impaired learning and memory function, according to the notion of a U-inverted relationship between stress systems activity and cognitive performance (Heinrichs et al., 1996; Contarino et al., 1999) . The elevated platform stressor used herein may be considered a relatively mild stressor since it does not influence NOR memory in control drug-naïve mice; yet, it induces the re-emergence of NOR deficits in cocaine-withdrawn wild-type mice, indicating a vulnerable state. This suggests that recovery reflects more of a 'masking' or 'compensation' phenomenon and not a normalization of the neural substrates underpinning cognitive performance. These findings add novel evidence to prior rat studies showing that a history of ethanol or opiate administration increases anxietylike responses to stressors three, seven days or six weeks after substance discontinuation, as assessed in the social interaction and the elevated plus-maze tests (Valdez et al., 2003; Blatchford et al., 2005; Breese et al., 2005) . Unlike the wild-type mice, herein, stress exposure does not impair NOR memory in cocaine-withdrawn CRF 2 −/− mice, revealing that functional CRF 2 receptors are essential to the long-lasting vulnerability to stress associated with drug withdrawal. It is unlikely that the resilience to stress observed in cocaine-withdrawn CRF 2 −/− mice is due to decreased negative affective-like responses, as compared to wild-type mice. Indeed, CRF 2 receptor-deficiency is reported to increase anxiety-like and depressive-like responses to stressors other than drug withdrawal (Bale et al., 2000; Bale and Vale, 2003) . Moreover, following exposure to the elevated platform stressor cocaine-withdrawn wild-type and CRF 2 −/− mice do not differ in the total time spent exploring objects during the T1 of the NOR test, a parameter thought to reflect affective-like states. Indeed, drugs with anxiolyticlike properties, such as vortioxetine, increase the total time spent exploring objects during the NOR test in rats (Mork et al., 2012 (Mork et al., , 2013 . To date, CRF role in the stress-induced re-emergence of cognitive deficits in long-term drug-withdrawn animals has been poorly investigated. Indeed, prior studies mainly report on CRF role in the stress-induced reinstatement of drug-seeking behaviour. For instance, the i.c.v. administration of the non-selective CRF receptor antagonist D-Phe CRF 12-41 attenuates the reinstatement of cocaine-seeking behaviour elicited by a foot-shock stress seven to twenty-one days after cocaine withdrawal (Erb et al., 1998) . Using CRF 2 receptor-preferring antagonists, studies also examine the role for the CRF 2 receptor in the stress-induced reinstatement of cocaineseeking behaviour. However, while one study reports that the intra-VTA administration of antisauvagine-30 attenuates the foot-shock stress-induced reinstatement of cocaine-seeking behaviour in rats, another study finds no effect of astressin-2B (Wang et al., 2007; Blacktop et al., 2011) . Differences in the experimental procedures and/or the CRF antagonists employed might underlie the latter discordant findings. However, to our knowledge neither behavioural nor receptor activity studies yet exist to support a CRF receptor type-selectivity for the currently available compounds. Indeed, although some compounds show higher CRF 2 (vs. CRF 1 ) in vitro receptor binding affinity (Ruhmann et al., 1998; Grace et al., 2007) , it cannot be excluded that in vivo they interact with both CRF receptor types, at least at the behaviourally active doses usually employed. Accordingly, recent evidence demonstrates that the putative CRF 2 receptorpreferring antagonist antisauvagine-30 similarly attenuates the duration of foot-shock-induced freezing behaviour in wild-type and CRF 2 −/− mice (Zorrilla et al., 2013) . On the other hand, CRF 2 −/− mice show preserved CRF 1 receptor activity, suggesting that they may be used to specifically address the role for the CRF 2 receptor in behaviour (Papaleo et al., 2008; Ingallinesi et al., 2012) . It cannot be excluded that compensatory developmental processes are associated with the life-long CRF 2 receptor-deficiency. However, in the present study drug-naive wild-type and CRF 2 −/− mice display similar recognition memory throughout the repeated NOR tests, even after exposure to the elevated platform stressor. This indicates that life-long CRF 2 receptor-deficiency does not induce major alterations in cognitive processes, suggesting that resilience to stress is not due to general developmental deficits. Moreover, prior studies indicate that CRF 1 receptor function is preserved in CRF 2 −/− mice. For instance, in CRF 2 −/− mice the CRF 1 receptorpreferring antagonist antalarmin effectively reverses conditioned place aversions induced by the kappa-opioid receptor agonist U-50,488H (Ingallinesi et al., 2012) . Furthermore, following morphine administration and withdrawal CRF 2 −/− mice display preserved plasma corticosterone increases, a biological response largely dependent on functional CRF 1 receptors (Papaleo et al., 2008) . Thus, in CRF 2 −/− mice, CRF 1 receptors may be functional and mediate negative affective-like and hypothalamus-pituitary-adrenal axis responses to stressful events. Nevertheless, mouse models of inducible CRF 2 receptor-deficiency might help to rule out the latter issue.
CRF 2 receptor-mediated NOR memory vulnerability to stress does not depend on other drug-and stress-related substrates Investigation of potential substrates that might underlie CRF 2 receptor-dependent cognitive vulnerability to stress reveals that long-term cocaine withdrawal is associated with increased neuronal reactivity (c-fos expression) in the rostral but not the caudal PRh. Moreover, neither genotype nor drug withdrawal affects c-fos expression in the PFC. This is intriguing since bilateral lesions of the PRh in rats and inhibition of protein synthesis in the PFC in mice impair NOR performance, suggesting a role for these brain structures in recognition memory (Barker et al., 2007; Nagai et al., 2007) . Studies also suggest a link between recognition memory and c-fos expression in the PRh or the PFC. Indeed, the L-type voltage-dependent calcium channel antagonist verapamil impairs NOR memory and decreases PRh c-fos expression, whereas environmental enrichment enhances NOR memory and increases PFC c-fos expression (Seoane et al., 2009; Leger et al., 2012) . In the present study, cocaine-withdrawn wild-type and CRF 2 −/− mice display a similar increase in PRh c-fos expression and no change in the PFC, as compared to control drug-naive mice. However, the elevated platform stressor disrupts NOR memory in cocaine-withdrawn wild-type but not CRF 2 −/− mice, suggesting that the latter brain regions may not necessarily be implicated in the stress-induced re-emergence of recognition memory deficits after a relatively long period of drug withdrawal.
Dopamine neurons originating from the VTA and projecting to the PFC might underlie recognition memory. For instance, muscimol-induced inactivation of the VTA disrupts NOR memory in rats (Rossato et al., 2013) . CRF-glutamate-dopamine interactions in the VTA are also hypothesized to contribute to the stress-induced reinstatement of cocaine-seeking behaviour (Wise and Morales, 2010) . Besides, norepinephrine systems originating from the LC are major modulators of brain, neuroendocrine and autonomic responses to stressful events (Koob, 2008; Ingallinesi et al., 2012) . However, the present results indicate that neither cocaine withdrawal nor CRF 2 receptor-deficiency influence the expression of the dopamine and norepinephrine synthesis enzyme TH in the VTA or the LC, suggesting that it might not be involved in cocaine withdrawal-induced cognitive vulnerability to stress. Cocaine withdrawal and stressors also increase CRF activity in the CeA and the PVN (Koob, 1999; Richter and Weiss, 1999; Maj et al., 2003) . However, despite the resilience of cocaine-withdrawn CRF 2 −/− mice to the stressor used herein, the present data indicate no effect of CRF 2 receptor-deficiency in CeA-CRF and PVN-CRF expression. However, prior studies report changes in emotional-and stress-related systems during early phases of substance withdrawal. In contrast, herein, gene expression is examined in mice exposed to a relatively mild stressor after a long period of cocaine withdrawal. Thus, different brain circuitry might mediate the behavioural effects of short-or long-term drug withdrawal periods.
Conclusions and perspectives
The present study demonstrates that genetic deletion of the CRF 2 receptor attenuates the duration of recognition memory deficits induced by cocaine withdrawal and eliminates their re-emergence following exposure to a stressor. In long-term cocaine-withdrawn animals, the CRF 2 receptor-dependent memory vulnerability to stress does not seem to depend on other neuronal markers of drug-and stress-related effects. Cognitive dysfunction and the long-lasting vulnerability to stress are critical features of substance use disorders. Thus, following psychostimulant drug withdrawal functional antagonism of the CRF 2 receptor might protect from the deleterious effects of stressors, thus reducing the rate of relapse to drug intake in former dependent drug-abstinent individuals.
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